Skip to main content
Clinical Trials/TCTR20210518001
TCTR20210518001
Not yet recruiting
Phase 2

Effect of oral dexamethasone for prevention of postembolization syndrome after hepatic conventional transarterial chemoembolization: A prospective randomized, double blinded, placebo controlled trial

THE GASTROENTEROLOGICAL ASSOCIATION OF THAILAND0 sites98 target enrollmentMay 18, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Postembolization syndrome after hepatic conventional transarterial chemoembolization
Sponsor
THE GASTROENTEROLOGICAL ASSOCIATION OF THAILAND
Enrollment
98
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2021
End Date
December 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Hepatocellular carcinoma
  • 2\. Child\-Pugh score \<\= 7
  • 3\. Indication for treatment with TACE

Exclusion Criteria

  • 1\.Main portal vein thrombosis
  • 2\.SMV and IVC thrombosis
  • 3\.Hepatosystemic shunt
  • 4\.Tumor size \> 50% of liver or \> 10 cm
  • 5\.Bile duct obstruction
  • 8\.HR\<50/min
  • 9\.TB\>3mg/dl
  • 10\.ANC\<1500
  • 11\.Platelet\<80,000
  • 12\.INR\>1\.5

Outcomes

Primary Outcomes

Not specified

Similar Trials